Transcranial Magnetic Stimulators Market Size by Type, Application, Region, Region – Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2029
Overview
Transcranial Magnetic Stimulators Market size was valued at US$ 1.58 Bn. in 2022 and the total revenue is expected to grow at 8.7% from 2022 to 2029, reaching nearly US$ 2.83 Bn.
The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.
To know about the Research Methodology :- Request Free Sample Report
Transcranial magnetic stimulation i.e. TMS is a magnetic process used to stimulate small areas of the brain.
Various medical factors are influencing the growth of the market for the transcranial magnetic stimulator. Neurological disorders are the prominent cause of disability and death across the world currently. The upsurge in the patient suffering from Multiple Sclerosis, Cerebrovascular, Epilepsy, Alzheimer’s, and Parkinson’s, offer ample growth opportunities for the TMS market globally. The MMR report analyzes factors affecting the TMS market from both demand and supply side and further estimates market dynamics affecting the market during 2022-2029 i.e., drivers, restraints, challenges, and opportunities.
In 2018, as per the ScienceDirect report, 5.8 million individuals in the United States were suffering from AD (Alzheimer's disease). Also, in the United States, as per study is found that every 65 seconds, somebody is diagnosed with Alzheimer's disease. As stated by the World Health Organization, in Europe proximate 10 million people are affected by dementia. The number of people suffering from dementia is likely to upsurge from 50 million in 2018 to 152 million by 2050. So, the growing prevalence of Alzheimer's disease along with dementia is likely to help TMS market growth.
North America transcranial magnetic stimulators market was valued at US$ xx million in 2022 and is expected to reach a value of US$ xx million by 2029, with a CAGR of xx.20% during the forecast period. Major demographic trends like growing geriatric population will prove helpful for industry growth. The ageing population base is inclined to chronic neurological disease that elevates the demand for TMS systems. Moreover, the positive regulatory situation for the market will activate the regional transcranial magnetic stimulators market growth.
The MMR report covers the segments in the transcranial magnetic stimulation market such as type and application. Based on type, deep transcranial magnetic stimulator (dTMS) segment dominated the transcranial magnetic stimulation market, with market size of US$ xx Mn in 2022 and to reach US$ XX Mn by 2029, with a CAGR of xx.29%. The dTMS is a process that uses magnetic fields created by a coil placed on the scalp. It also permits non-invasive treatment of the area of the deep brain for those suffering from neurological disorders, like depression.
By application, the depression segment is dominating the TMS market and valued around US$ XX Mn in 2022. As per the World Health Organization, in 2018, over half of the population diagnosed with depression is getting treatment, like therapies and medication. Also, according to MHA (Mental Health America), around half of the US population has a mental health condition, like MDD (Major Depressive Disorder). Hence, a high incidence of depression globally can attribute to the major market share of the segment.
In recent years, major players in the transcranial magnetic stimulators market have taken various strategic measures, such as partnerships and facility expansions. In Sept 2017, eNeura Company received FDA support for eNeura spring transcranial magnetic stimulators, which is designed for the prophylactic and important treatment of migraine.
The objective of the report is to present a comprehensive analysis of the Global Transcranial Magnetic Stimulators Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Transcranial Magnetic Stimulators Market dynamics, structure by analyzing the market segments and projects the Global Transcranial Magnetic Stimulators Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Transcranial Magnetic Stimulators Market make the report investor’s guide.
Transcranial Magnetic Stimulators Market Scope : Inquire before buying
| Transcranial Magnetic Stimulators Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2017 to 2022 | Market Size in 2022: | US $ 1.58 Bn. |
| Forecast Period 2023 to 2029 CAGR: | 8.7% | Market Size in 2029: | US $ 2.83Bn. |
| Segments Covered: | by Type | • Deep Transcranial Magnetic Stimulator (dTMS) • Repetitive Transcranial Magnetic Stimulator (rTMS) • Others |
|
| by Application | • Alzheimer’s Disease • Depression • Parkinson’s Disease • Epilepsy • Others |
||
| by Region | • North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America) |
||
Transcranial Magnetic Stimulators Market Key players
• Axilum Robotics
• Mastigm
• Nexstim plc
• Neuronetics, Inc.
• Brainsway Ltd.
• TMS Neuro Solutions
• Yiruide
• Neurosoft
• eNeura
• MagVenture
• Remed
• Dr. Langer Medical
Frequently Asked Questions:
1. Which region has the largest share in Global Transcranial Magnetic Stimulators Market?
Ans: North America region held the highest share in 2022.
2. What is the growth rate of Global Transcranial Magnetic Stimulators Market?
Ans: The Global Transcranial Magnetic Stimulators Market is growing at a CAGR of 8.7% during forecasting period 2023-2029.
3. What is scope of the Global Transcranial Magnetic Stimulators Market report?
Ans: Global Transcranial Magnetic Stimulators Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Transcranial Magnetic Stimulators Market?
Ans: The important key players in the Global Transcranial Magnetic Stimulators Market are – Axilum Robotics, Mastigm, Nexstim plc, Neuronetics, Inc., Brainsway Ltd., TMS Neuro Solutions, Yiruide, Neurosoft, eNeura, MagVenture, Remed, and Dr. Langer Medical
5. What is the study period of this Market?
Ans: The Global Transcranial Magnetic Stimulators Market is studied from 2022 to 2029.